Abstract 276: Gender Disparity in the Treatment of Aortic Stenosis-an Analysis of the National Inpatient Sample 2009-2015
Background: It is well known that there is a significant gender gap in both the referral and outcomes of patients
Read moreBackground: It is well known that there is a significant gender gap in both the referral and outcomes of patients
Read moreBackground: Concerns exist that mortality benefit might vary across different drugs (canagliflozin, empagliflozin, dapagliflozin) belonging to sodium-glucose cotransporter-2 (SGLT2) inhibitors.
Read moreBackground: Cardiovascular disease (CVD) and cancer are the leading causes of mortality among adult women in the United States (US),
Read moreBackground: Readmission reduction initiatives emphasize prompt follow-up post-discharge. Identifying factors that influence early readmission may inform discharge planning. We compared
Read moreBackground: There is a paucity of data regarding prevalence of cardiovascular disease (CVD) and corresponding cardiovascular (CV) risk factors in
Read moreBackground: The primary indication for coronary revascularization in patients with stable ischemic heart disease (SIHD) is relief of angina and
Read moreIntroduction: Out-of-pocket costs (OOPC) are a significant barrier to care and drive suboptimal medical therapy in ASCVD. Despite this, there
Read moreBackground: The mortality rate of US Veterans is greater than that of civilians, and US Veterans experience disproportionately higher burden
Read moreRecent improvements in survival and management of patients with cardiovascular disease (CVD) have resulted from timely use of medications such
Read moreBackground: Prevalence of coexisting comorbidities in clinical trials of lipid lowering therapies remains uncertain. Methods: We selected 61 trials (n
Read more